Discontinued Product(2S,4S)-Methylglutamic acid (Cat. No. 0814) has been withdrawn from sale for commercial reasons.
Glutamate receptor agonist displaying some selectivity for kainate and mGlu receptors (mGlu1α and mGlu2).
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
References are publications that support the biological activity of the product.
Brauner-Osborne et al (1997) Molecular pharmacology of 4-substituted glutamic acid analogues at ionotropic and metabotropic excitatory amino acid receptors. Eur.J.Pharmacol. 335 R1-R3 PMID: 9369383
Jones et al (1997) Desensitization of kainate receptors by kainate, glutamate and diastereomers of 4-methylglutamate. Neuropharmacology 36 853 PMID: 9225313
View Related Products by Target
Keywords: (2S,4S)-Methylglutamic acid, (2S,4S)-Methylglutamic acid supplier, Non-selective, mGlu, 0814, Tocris Bioscience
Citations for (2S,4S)-Methylglutamic acid
Citations are publications that use Tocris products.
Currently there are no citations for (2S,4S)-Methylglutamic acid.
Reviews for (2S,4S)-Methylglutamic acid
There are currently no reviews for this product. Be the first to review (2S,4S)-Methylglutamic acid and earn rewards!
Have you used (2S,4S)-Methylglutamic acid?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Epilepsy is a brain disease that affects 60 million people globally. More than 20 anti-seizure drugs are currently available, but these do not address the underlying causes of the condition. This poster summarizes current knowledge about the development of the condition and highlights some approaches that have disease-modifying effects in proof-of-concept studies.
Learning & Memory Poster
Recognition memory enables us to make judgements about whether or not we have encountered a particular stimulus before. This poster outlines the cellular mechanisms underlying recognition memory and its links to long-term depression, as well as the use of pharmacological intervention to assess the role of neurotransmitters in recognition memory.
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.